Feb 21 (Reuters) - Biocon Ltd:
* U.S. FDA COMPLETED PRE-APPROVAL INSPECTION AT MALAYSIA FACILITY AND ISSUED FORM 483 WITH 6 OBSERVATIONS Source text - bit.ly/2EUL56I Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.
Feb 21 (Reuters) - Biocon Ltd:
* U.S. FDA COMPLETED PRE-APPROVAL INSPECTION AT MALAYSIA FACILITY AND ISSUED FORM 483 WITH 6 OBSERVATIONS Source text - bit.ly/2EUL56I Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.